Maine is among 20 states that are suing six makers of generic drugs with a claim that the companies artificially inflated prices for an antibiotic and an oral diabetes medication.
Attorney General Janet Mills says the federal lawsuit accuses the companies of manipulating prices and reducing competition for two drugs that many residents buy as lower-cost generics.
She accuses the drugmakers of putting profits over people who need affordable medicine.
The lawsuit was filed Thursday in U.S. District Court in Connecticut. The companies targeted in the lawsuit are Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma, Mayne Pharma (USA), Mylan Pharmaceuticals and Teva Pharmaceuticals USA.
The lawsuit stems from a Connecticut state investigation of the reasons for prices increases of certain generic pharmaceuticals. That investigation is ongoing.
Send questions/comments to the editors.
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.